IBM (IBM) Shares Sold by Raymond James Financial Services Advisors Inc.

Raymond James Financial Services Advisors Inc. reduced its stake in shares of IBM (NYSE:IBM) by 9.4% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 153,063 shares of the technology company’s stock after selling 15,867 shares during the period. Raymond James Financial Services Advisors Inc.’s holdings in IBM were worth $23,484,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of IBM. Vanguard Group Inc. lifted its stake in IBM by 3.7% in the second quarter. Vanguard Group Inc. now owns 62,228,040 shares of the technology company’s stock worth $9,572,538,000 after purchasing an additional 2,241,818 shares during the last quarter. Nordea Investment Management AB lifted its stake in IBM by 151.2% in the second quarter. Nordea Investment Management AB now owns 3,250,047 shares of the technology company’s stock worth $499,955,000 after purchasing an additional 1,956,033 shares during the last quarter. Janus Henderson Group PLC lifted its stake in IBM by 1,155.3% in the second quarter. Janus Henderson Group PLC now owns 1,358,103 shares of the technology company’s stock worth $208,923,000 after purchasing an additional 1,249,916 shares during the last quarter. BlackRock Inc. lifted its stake in IBM by 2.4% in the second quarter. BlackRock Inc. now owns 52,936,360 shares of the technology company’s stock worth $8,143,204,000 after purchasing an additional 1,241,441 shares during the last quarter. Finally, Stifel Financial Corp lifted its stake in IBM by 9,678.2% in the third quarter. Stifel Financial Corp now owns 815,897 shares of the technology company’s stock worth $118,347,000 after purchasing an additional 807,553 shares during the last quarter. 57.02% of the stock is owned by institutional investors.

How to Become a New Pot Stock Millionaire

In related news, insider Diane J. Gherson sold 5,000 shares of the business’s stock in a transaction dated Monday, February 26th. The shares were sold at an average price of $156.00, for a total transaction of $780,000.00. Following the sale, the insider now owns 20,581 shares of the company’s stock, valued at $3,210,636. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Frederick H. Waddell acquired 610 shares of the company’s stock in a transaction that occurred on Wednesday, January 31st. The shares were acquired at an average cost of $163.38 per share, for a total transaction of $99,661.80. The disclosure for this purchase can be found here. 0.17% of the stock is owned by insiders.

Shares of NYSE IBM opened at $150.57 on Monday. IBM has a 1 year low of $139.13 and a 1 year high of $172.93. The company has a debt-to-equity ratio of 2.25, a quick ratio of 1.29 and a current ratio of 1.33. The stock has a market cap of $138,700.28, a P/E ratio of 10.91, a P/E/G ratio of 2.20 and a beta of 0.90.

IBM (NYSE:IBM) last announced its quarterly earnings results on Thursday, January 18th. The technology company reported $5.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.17 by $0.01. IBM had a net margin of 7.27% and a return on equity of 69.48%. The company had revenue of $22.54 billion for the quarter, compared to analysts’ expectations of $22.03 billion. During the same quarter in the previous year, the company earned $5.01 earnings per share. IBM’s quarterly revenue was up 3.6% on a year-over-year basis. equities analysts predict that IBM will post 13.82 EPS for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Saturday, March 10th. Investors of record on Friday, February 9th were given a dividend of $1.50 per share. This represents a $6.00 annualized dividend and a dividend yield of 3.98%. The ex-dividend date of this dividend was Thursday, February 8th. IBM’s dividend payout ratio is currently 43.48%.

Several analysts have weighed in on the stock. Cantor Fitzgerald reissued a “hold” rating and issued a $152.00 price target on shares of IBM in a research note on Friday, January 19th. Zacks Investment Research downgraded shares of IBM from a “hold” rating to a “sell” rating in a research note on Tuesday, December 19th. JPMorgan Chase set a $167.00 price target on shares of IBM and gave the stock a “neutral” rating in a research note on Friday, January 19th. Goldman Sachs set a $170.00 price target on shares of IBM and gave the stock a “neutral” rating in a research note on Friday, January 19th. Finally, Royal Bank of Canada restated a “buy” rating and issued a $180.00 price objective on shares of IBM in a research report on Friday, January 19th. Six investment analysts have rated the stock with a sell rating, seventeen have given a hold rating and eleven have given a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $166.01.

ILLEGAL ACTIVITY WARNING: “IBM (IBM) Shares Sold by Raymond James Financial Services Advisors Inc.” was first reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this report on another publication, it was stolen and reposted in violation of US and international copyright & trademark laws. The original version of this report can be viewed at https://www.dispatchtribunal.com/2018/04/09/ibm-ibm-shares-sold-by-raymond-james-financial-services-advisors-inc.html.

IBM Company Profile

International Business Machines Corporation operates as an integrated technology and services company worldwide. Its Cognitive Solutions segment offers Watson, a cognitive computing platform that interacts in natural language, processes big data, and learns from interactions with people and computers.

Institutional Ownership by Quarter for IBM (NYSE:IBM)

Receive News & Ratings for IBM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for IBM and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply